GHP December

28 | ghp December 2016 Research & Development Mio Global’s Personal Activity Intelligence (PAI) Algorithm recognised pioneer in sports and fitness technology with distribution around the world, Mio is known for its industry- leading heart rate monitor technology and wearables. The company was founded by CEO Liz Dickinson, a visionary in the fitness technology sector, who holds numerous patents. Mio offers a range of heartrate monitoring watches and wristbands, including award- winning wearables such as Mio ALPHA, Mio FUSE, Mio LINK, and later this year, Mio SLICE, as well as advanced technologies such as PAI – Personal Activity Intelligence – a revolutionary new system and metric to manage one’s health through exercise by tracking activity levels based on heart rate. Mio’s deep R&D capabilities in machine learning and AI have positioned them to become a technology company with a mission to license its technologies to others to make wearables meaningful. Mio continues to deliver the world’s most accurate heart rate and heart rate variability in motion and other biometric sensing capabilities. What is PAI? PAI is a scientifically proven way of personalising physical activity and exercise recommendations to substantially reduce the risk of premature cardiovascular disease and death. Rather than taking a “one-size-fits all” approach to fitness monitoring via step count, distance tracking or duration, PAI provides a weekly target score of 100 or more PAI that is associated with increased longevity and reduced risk of lifestyle-related diseases by up to 38 percent. To get this score, PAI translates your heart rate from any physical activity and personal profile data (age, gender, resting and maximum heart rate) into easily understandable PAI points. Mio Global, a health technology company, announces the publication of the first scientific study supporting its ground- breaking personal health metric – Personal Activity Intelligence (PAI) – in The American Journal of Medicine. Ultimately, there has never been a prescription for the exact amount of exercise you need, until now, as PAI prescribes the right amount of activity needed to reduce the risk of premature death, and seeks to motivate people to become and stay physically active. The PAI Study Insights The study was done by the Nobel Prize Winning Norwegian University of Science and Technology (NTNU) and co-authored by renowned researchers, Dr. Carl Lavie, Cardiologist at John Ochsner Heart and Vascular Institute, New Orleans, and Professor Ulrik Wisloff, Head of CERG (Cardiac Exercise Research Group) at NTNU. The algorithms used to create PAI are based on the HUNT Study, a unique study of more than 45,000 individuals that have been closely monitored over 25 years, gathering one of the largest data sets ever collected for the analysis of lifestyle choices and physiological profiles. By utilising data from the HUNT database and applying the PAI algorithm to men and women, specifically to mortality rates in the group, this study is the first to clearly identify the amount of physical activity needed to help protect against lifestyle- related diseases. Men and women with a weekly PAI score of 100 or greater had on average a 17 percent and 23 percent reduced risk of cardiovascular disease mortality compared to the inactive groups. Obtaining a minimum of 100 PAI was associated with significantly lower risk for cardiovascular disease mortality in all age groups and in participants with known cardiovascular disease risk factors (type 2 diabetes, hypertension and obesity). Participants who did not obtain 100 or more PAI had increased risk of dying regardless of meeting the physical activity recommendations (at least 150 minutes of moderate intensity activity or 75 minutes of vigorous intensity activity per week), which proves that keeping your PAI score at 100 or above is more effective than following today’s exercise guidelines and validates that intensity and quality of exercise matters. A

RkJQdWJsaXNoZXIy NTg0MjY4
http://www.biopharma.co.uk/